−0.38EUR
−8.28 MEUR
55.34 MEUR
10.11 M
About BRAIN BIOTECH AG NPV
Sector
Industry
CEO
Adriaan Moelker
Website
Headquarters
Zwingenberg
Employees (FY)
309
Founded
1993
ISIN
DE0005203947
FIGI
BBG00NRVY799
BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. It operates through the BioScience and BioIndustrial segments. The BioScience segment works on enzymes and performance microorganisms; and collaborates with industrial partners. The BioIndustrial segment deals with the bioproduct and cosmetics businesses. The company was founded by Holger Zinke, Jüngen Eck, and Hans Günter Gassen on September 22, 1993 and is headquartered in Zwingenberg, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0RFI is 3.20 EUR — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange BRAIN BIOTECH AG NPV stocks are traded under the ticker 0RFI.
BRAIN BIOTECH AG NPV is going to release the next earnings report on May 28, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for BRAIN BIOTECH AG NPV has a max estimate of 15.00 EUR and a min estimate of 4.10 EUR.
Yes, you can track BRAIN BIOTECH AG NPV financials in yearly and quarterly reports right on TradingView.
Like other stocks, 0RFI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BRAIN BIOTECH AG NPV stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 309.00 employees. See our rating of the largest employees — is BRAIN BIOTECH AG NPV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BRAIN BIOTECH AG NPV EBITDA is −2.49 M EUR, and current EBITDA margin is −3.72%. See more stats in BRAIN BIOTECH AG NPV financial statements.